Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Matthews

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Iscience|October 20, 2023
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunityHazel Stewart, Yongxu Lu, Sarah O'Keefe, et al.
Journal of Medicinal Chemistry|May 3, 2002
Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C proteaseTheodore O Johnson, Ye Hua, Hiep T Luu, et al.
Journal of Medicinal Chemistry|April 5, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Genome Biology|January 20, 2017
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusXuan Liu, Emily Speranza, César Muñoz-Fontela, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Msphere|July 21, 2021
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERSWaleed Aljabr, Muhannad Alruwaili, Rebekah Penrice-Randal, et al.
Genome Biology|March 14, 2023
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infectionHannah Goldswain, Xiaofeng Dong, Rebekah Penrice-Randal, et al.
Journal of Medicinal Chemistry|October 3, 2003
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Viruses|October 17, 2020
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon AntagonismShona C Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Iscience|October 20, 2023
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunityHazel Stewart, Yongxu Lu, Sarah O'Keefe, et al.
Journal of Medicinal Chemistry|May 3, 2002
Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C proteaseTheodore O Johnson, Ye Hua, Hiep T Luu, et al.
Journal of Medicinal Chemistry|April 5, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Genome Biology|January 20, 2017
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusXuan Liu, Emily Speranza, César Muñoz-Fontela, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Msphere|July 21, 2021
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERSWaleed Aljabr, Muhannad Alruwaili, Rebekah Penrice-Randal, et al.
Genome Biology|March 14, 2023
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infectionHannah Goldswain, Xiaofeng Dong, Rebekah Penrice-Randal, et al.
Journal of Medicinal Chemistry|October 3, 2003
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Viruses|October 17, 2020
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon AntagonismShona C Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, et al.
Pageof 9